MedImmune announced the addition of two new vice presidents Tuesday, going forward with business as usual even as the company comes under fire from shareholders for disappointing sales.
Gaithersburg-based MedImmune, the Washington region’s most successful biotechnology firm by revenue, hired Jamie Harrell to spearhead the marketing strategy for the company’s high-profile Synagis product and Mark Stanton to oversee the marketing for the products in MedImmune’s managed care portfolio.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.